Literature DB >> 29390105

Respiratory Syncytial Virus Seasonality: A Global Overview.

Pablo Obando-Pacheco1,2, Antonio José Justicia-Grande1,2, Irene Rivero-Calle1,2, Carmen Rodríguez-Tenreiro1,2, Peter Sly3, Octavio Ramilo4,5,6, Asunción Mejías4,5,6, Eugenio Baraldi4,7, Nikolaos G Papadopoulos4,8,9, Harish Nair4,10, Marta C Nunes4,11,12, Leyla Kragten-Tabatabaie4,13, Terho Heikkinen4,14, Anne Greenough4,15,16,17, Renato T Stein4,18, Paolo Manzoni4,19, Louis Bont4,20,21, Federico Martinón-Torres1,2,4.   

Abstract

Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory infections in children. By the age of 1 year, 60%-70% of children have been infected by RSV. In addition, early-life RSV infection is associated with the development of recurrent wheezing and asthma in infancy and childhood. The need for precise epidemiologic data regarding RSV as a worldwide pathogen has been growing steadily as novel RSV therapeutics are reaching the final stages of development. To optimize the prevention, diagnosis, and treatment of RSV infection in a timely manner, knowledge about the differences in the timing of the RSV epidemics worldwide is needed. Previous analyses, based on literature reviews of individual reports obtained from medical databases, have failed to provide global country seasonality patterns. Until recently, only certain countries have been recording RSV incidence through their own surveillance systems. This analysis was based on national RSV surveillance reports and medical databases from 27 countries worldwide. This is the first study to use original-source, high-quality surveillance data to establish a global, robust, and homogeneous report on global country-specific RSV seasonality.

Entities:  

Mesh:

Year:  2018        PMID: 29390105     DOI: 10.1093/infdis/jiy056

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  71 in total

1.  Discovery of a Potent Dual Inhibitor of Wild-Type and Mutant Respiratory Syncytial Virus Fusion Proteins.

Authors:  Toru Yamaguchi-Sasaki; Seiken Tokura; Yuya Ogata; Takanori Kawaguchi; Yutaka Sugaya; Ryo Takahashi; Kanako Iwakiri; Tomoko Abe-Kumasaka; Ippei Yoshida; Kaho Arikawa; Hiroyuki Sugiyama; Kosuke Kanuma
Journal:  ACS Med Chem Lett       Date:  2020-04-10       Impact factor: 4.345

2.  Seasonality, molecular epidemiology, and virulence of Respiratory Syncytial Virus (RSV): A perspective into the Brazilian Influenza Surveillance Program.

Authors:  Lucas A Vianna; Marilda M Siqueira; Lays P B Volpini; Iuri D Louro; Paola C Resende
Journal:  PLoS One       Date:  2021-05-18       Impact factor: 3.240

3.  Changes in Bronchiolitis Incidence During the Last Two Decades in Tampere, Finland: A Retrospective Study.

Authors:  Tytti Vihikangas; Sauli Palmu; Anna-Maija Koivisto; Paula Heikkilä
Journal:  Pediatr Infect Dis J       Date:  2022-07-28       Impact factor: 3.806

4.  Out-of-Season Epidemic of Respiratory Syncytial Virus during the COVID-19 Pandemic: The High Burden of Child Hospitalization in an Academic Hospital in Southern Italy in 2021.

Authors:  Daniela Loconsole; Francesca Centrone; Caterina Rizzo; Désirée Caselli; Azzurra Orlandi; Fabio Cardinale; Cristina Serio; Paola Giordano; Giuseppe Lassandro; Leonardo Milella; Maria Teresa Ficarella; Maria Elisabetta Baldassarre; Nicola Laforgia; Maria Chironna
Journal:  Children (Basel)       Date:  2022-06-08

5.  Respiratory syncytial virus among children hospitalized with severe acute respiratory infection in Kashmir, a temperate region in northern India.

Authors:  Parvaiz A Koul; Siddhartha Saha; Kaisar A Kaul; Hyder Mir; Varsha Potdar; Mandeep Chadha; Danielle Iuliano; Kathryn E Lafond; Renu B Lal; Anand Krishnan
Journal:  J Glob Health       Date:  2022-07-16       Impact factor: 7.664

6.  Prefusion F-Based Polyanhydride Nanovaccine Induces Both Humoral and Cell-Mediated Immunity Resulting in Long-Lasting Protection against Respiratory Syncytial Virus.

Authors:  Laura M Stephens; Kathleen A Ross; Kody A Waldstein; Kevin L Legge; Jason S McLellan; Balaji Narasimhan; Steven M Varga
Journal:  J Immunol       Date:  2021-04-07       Impact factor: 5.422

7.  Epidemiology and factors associated with the severity of viral acute lower respiratory infection in children hospitalized in Manaus, Amazonas, in 2017-2018: An observational study.

Authors:  Fabrícia L D V Sobrinho; Davi C Aragon; Ana P C P Carlotti
Journal:  Medicine (Baltimore)       Date:  2021-05-07       Impact factor: 1.889

8.  Delayed season's onset and reduction of incidence of bronchiolitis during COVID-19 pandemic.

Authors:  Sergio Ghirardo; Nicola Ullmann; Marta L Ciofi Degli Atti; Massimiliano Raponi; Renato Cutrera
Journal:  Pediatr Pulmonol       Date:  2021-05-18

9.  The Association between Weather Conditions and Admissions to the Paediatric Intensive Care Unit for Respiratory Syncytial Virus Bronchiolitis.

Authors:  Rosalie S Linssen; Bibiche den Hollander; Louis Bont; Job B M van Woensel; Reinout A Bem
Journal:  Pathogens       Date:  2021-05-07

10.  Assessing the impact of air pollution and climate seasonality on COVID-19 multiwaves in Madrid, Spain.

Authors:  Maria A Zoran; Roxana S Savastru; Dan M Savastru; Marina N Tautan; Laurentiu A Baschir; Daniel V Tenciu
Journal:  Environ Res       Date:  2021-08-06       Impact factor: 8.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.